Results 71 to 80 of about 14,685,807 (300)

Off-target analyses.

open access: yes, 2023
Off-targets of PPR56, PPR56|S4TN>TD and PPR56|S10TD>TN in the E.coli transcriptome summarized with Weblogo [89]. Consensus profiles were created from the sequences of 119, 382 and 15 C-to-U RNA editing off-targets, weighted with their respective editing ...
Jingchan Xie (16859288)   +5 more
core   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

Comparative analysis of antibody-mediated loss-of-function versus gene knock-out and knock-down

open access: yesSLAS Discovery
In this study we compare three methods for manipulating cell function: RNA interference (RNAi), CRISPR-Cas9 gene knock-out, and antibody-mediated loss-of-function.
Marie Buck-Wiese   +3 more
doaj   +1 more source

Intriguing Off-Target Effects of Ezetimibe

open access: yesJournal of the American College of Cardiology, 2015
Tsujita et al. [(1)][1] report patients randomized to atorvastatin + ezetimibe therapy experienced a greater reduction in the percentage of atheroma volume than those randomized to atorvastatin, and it may be due to the lower mean low-density lipoprotein cholesterol achieved.
openaire   +2 more sources

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

MOESM2 of Rapid generation and selection of Cas9-engineering TRP53 R172P mice that do not have off-target effects

open access: yes, 2019
Additional file 2: Figure S2. No off-target effects were found in all the offspring of mice that did not carry off-target locus. (A) PCR identifications of KI offspring of mice not carrying #1 off-target locus were validated by gel electrophoresis.
Junchao Dong (7582535)   +4 more
core   +1 more source

The impact of Relative Prevalence on dual-target search for threat items from airport X-ray screening [PDF]

open access: yes, 2010
The probability of target presentation in visual search tasks influences target detection performance: thisis known as the prevalence effect (Wolfe et al., 2005).
Cave, K.R.   +11 more
core   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

A novel ROCK inhibitor: off-target effects of metformin

open access: yesTURKISH JOURNAL OF BIOLOGY, 2021
In drug discovery, most small molecules cannot cross many stages, only a few can become drug candidates. Once the drug molecule is approved and marketed, nontarget effects that are not easily distinguishable from the actual target of the drugs might be evaluated. This situation restricts the treatment.
Aysun ÖZDEMİR, Mustafa ARK
openaire   +3 more sources

Target deconvolution of the HDAC pharmacopoeia highlights MBLAC2 as a common off-target

open access: yes, 2022
This dataset contains the untargeted lipidomics data for the publication Lechner et al. 2022 "Target deconvolution of the HDAC pharmacopoeia highlights MBLAC2 as a common off-target". The dataset has also been submitted to MetaboLight repository with ID
Severin Lechner, Guillaume Médard
core   +1 more source

Home - About - Disclaimer - Privacy